Retacrit® (epoetin zeta) is the first biosimilar epoetin to achieve a subcutaneous licence in renal anaemia
Year: 2010; Nr: 3; Pages: 46- 47;- Congresses
- EJHP Journals
- Academy
- News
- Advocacy
- Calendars
- EAHP survey
- General Assemblies
- Hospital Pharmacy
- Useful links
- About
